documents: FDA-2022-N-3226-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-3226-0001 FDA FDA-2022-N-3226 Opportunity for Feedback on Development and Dissemination of Educational Materials on Rare Disease Drug Development Other Public Participation 2022-12-16T05:00:00Z 2022 12 2022-12-16T05:00:00Z 2023-05-01T03:59:59Z 2026-01-03T12:25:16Z   1 0 090000648553affa

Links from other tables